Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EOS Health vs TrueMe

EOS Health
Graded #268

Lower grade

vs+4.799999999999997
TrueMe
Graded #169

Higher grade

The verdict

TrueMe takes it — 67.6/100 to 62.8/100.

TrueMe grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TrueMe is a cash-pay telehealth brand offering compounded semaglutide and tirzepatide with added B vitamins, alongside NAD+, sermorelin and glutathione.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrueMe +18
44
62
Dose & formulationTrueMe +13
64
77
Clinical oversightEOS Health +9
87
78
Labs & monitoringEOS Health +14
66
52
FulfillmentEOS Health +3
84
81
Contract termsTrueMe +25
20
45
EOS Health · left barTrueMe · right bar

The numbers

MetricEOS HealthTrueMe
WeighScore62.8/10067.6/100
GradeCC
Scorecard rank#268#169
Semaglutide$199/mo (compounded)$159/mo (compounded)
Tirzepatide$289/mo (compounded)$189/mo (compounded)
Coverage40 states6 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
EOS Health

Graded #268 · C

Strengths

  • Unusually transparent: publicly names its clinical partner (Arora Health & Aesthetics, LLC) and pharmacy partner (F&F Pharmacies dba Jungle Jim's)
  • Competitive compounded pricing from $199/mo semaglutide and $289/mo tirzepatide, plus $100 off the first prescription with code WELCOME100
  • Multiple compounded formulas (semaglutide, semaglutide+glycine, semaglutide+B12, tirzepatide) and optional 130+ biomarker lab add-ons
  • Free expedited shipping, no insurance required, 10-minute intake, and an ongoing care team via patient portal

Where it loses points

  • Available in only 40 states — not offered in CA, NV, NJ, SC, TX, MA, MS, NH, WV, or DE (pharmacy partner is unlicensed there)
  • Headline prices are 'best rate' figures; standard monthly plans may cost more than the quarterly-plan rate shown
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path
  • Pharmacy partner's page notes it 'cannot dispense sterile compounds,' which is worth confirming for injectable GLP-1 fulfillment
TrueMe

Graded #169 · C

Strengths

  • One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
  • Same price at every dose, so the cost does not climb as a provider titrates the dose upward
  • Full pricing is published up front — no intake form is required before you can see what you will pay
  • Carries a genuine LegitScript-issued seal (ID 50205625) that resolves on LegitScript's own asset host
  • Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas

Where it loses points

  • Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
  • Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
  • You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
  • The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
  • A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard